Ghana

The PSI/Ghana office was opened in January 2015.

The Ghana Social Marketing Program (GSMP) distributes a variety of contraceptive products, including male contraceptives as well as oral and injectable contraceptives. Distribution is nationwide, through private sector pharmaceutical distributors. Additionally, PSI conducts behavior change communication campaigns through a range of media, including television, radio, print and special events.

PSI is in the process of setting up a local non-governmental organization, which will take over social marketing activities for the GSMP beginning in 2018.

Ghana is also part of the Sanitation Service Delivery Program,  a regional project that works with partners Water and Sanitation for the Urban Poor (WSUP) and PATH to implement project activities in Ghana, Côte d’Ivoire and Benin. The main objectives are to increase access to basic sanitation and improved fecal sludge management for urban slum populations and to share information and best practices.

• Being Tactical from the Start: Analyzing Use and Need Helps See Potential for Scale and Equity
  
• Strategies, Approaches and Tools Used to Introduce Next Generation Injectable Contraceptives in Resource Poor Settings
  This workshop set out to identify different service delivery models share strategies and best practice, explore how DMPA-SC is being used within the wider method mix, and ultimately develop action plans for strengthening high quality DMPA-SC programming and implementation in participants’ respective countries.
• Catalyzing Markets for Urban Sanitation in West Africa
  
• Shaping the Family Planning Market by Strengthening the Public Sector
  PSI considers total market approaches to be critical for achieving universal health coverage, especially when it comes to contraception. This program brief presents cases, supported by several different donors, which take into consideration the total family planning market.
• Effect of the Affordable Medicines Facility-Malaria (AMFm) on the Availability, Price, and Market Share of Quality-Assured Artemisinin-Based Combination Therapies in Seven Countries: A Before-and-After Analysis of Outlet Survey Data
  In 2010, the Global Fund launched the Affordable Medicines Facility—malaria (AMFm), a series of national-scale pilot programmes designed to increase the access and use of quality-assured artemisinin based combination therapies (QAACTs) and reduce that of artemisinin monotherapies for treatment of malaria. We present findings on the effect of AMFm on QAACT price, availability, and market share, 6–15 months after the delivery of subsidised ACTs in Ghana, Kenya, Madagascar, Niger, Nigeria, Uganda, and Tanzania (including Zanzibar).
• Measuring Client Satisfaction and the Quality of Family Planning Services: a Comparative Analysis of Public and Private Health Facilities in Tanzania, Kenya and Ghana
  This analysis seeks to quantify differences in the quality of family planning services at public and private providers in three representative sub- Saharan African countries (Tanzania, Kenya and Ghana), to assess how these quality differentials impact upon FP clients’ satisfaction, and to suggest how quality improvements can improve contraceptive continuation rates.